Market Share of Biomedical Pressure Sensors Industry
The biomedical pressure sensors market is anticipated to face significant competitive challenges during the forecast period due to the limited number of manufacturers. Market leaders, including Resonetics LLC, RJC Enterprises LLC, All Sensors Corporation, and Opsens Inc., exert considerable influence on the market. These companies have grown their operations by focusing on strategic expansions and acquisitions.
- March 2024 - Haydale has developed a series of functionalized biomedical sensor inks designed for biosensing and diagnostic purposes. These inks incorporate functional groups that facilitate interactions with biological molecules such as proteins and DNA, thereby enabling the detection of specific analytes. The biosensor has been engineered to identify particular electrochemical urinary microRNAs, thereby removing the need for invasive biopsies in diagnosing delayed graft function in kidney transplant recipients.
- November 2023 - Millar announced its strategic intention to acquire Sentron, a leading manufacturer of pressure and pH sensors, based in Leek, The Netherlands. Sentron, currently under the ownership of Wellinq, has been known for its fully integrated sensor solutions. This move underscores Millar's dedication to pushing the boundaries of medical knowledge and facilitating scientific breakthroughs, particularly in the realm of pressure sensor technology. By uniting under a common vision of excellence, this acquisition not only sets the stage for Millar to revolutionize medical sensor technology but also promises to catalyze advancements in global healthcare outcomes.
Biomedical Pressure Sensors Market Leaders
-
Resonetics LLC
-
RJC Entreprises LLC
-
All Sensors Corporation (Amphenol Corporation)
-
Opsens Inc.
-
Sensirion Holding AG
*Disclaimer: Major Players sorted in no particular order
